DMD and spinal muscular atrophy, type 1: In addition, the development and commercial introduction of highly effective therapies for monogenic conditions previously associated with early lethality, such as SMA type I and DMD [68,69,151,152,153,154,155], encourage the prediction that in the future an even greater proportion of these patients will be able to reach reproductive age and consequently require access to assisted reproductive techniques.